Miller Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$505K Sell
17,691
-200
-1% -$5.32K 0.38% 76
2026
Q2
$431K Sell
17,891
-50
-0.3% -$1.31K 0.35% 84
2026
Q1
$504K Sell
17,941
-340
-2% -$9.05K 0.55% 61
2025
Q4
$455K Buy
18,281
+300
+2% +$7.56K 0.53% 55
2025
Q3
$458K Sell
17,981
-212
-1% -$5.23K 0.53% 59
2025
Q2
$441K Buy
18,193
+830
+5% +$19.4K 0.56% 58
2025
Q1
$440K Buy
17,363
+1,133
+7% +$29.6K 0.63% 53
2024
Q4
$431K Buy
+16,230
New +$440K 0.36% 85

Other funds holding PFE

Miller Financial Services's PFE Position: Q3 2026 in Review

Miller Financial Services reduced its Pfizer (PFE) stake by 1.1% in Q3 2026, selling an estimated $5.32K and leaving 17,691 shares worth $505K. The position accounts for 0.38% of the portfolio, ranked #76.

Miller Financial Services first reported a position in PFE in Q4 2024 and has held it in 8 quarters since. 1,861 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Miller Financial Services held 17,691 shares of Pfizer worth $505K as of Q3 2026.
  • Miller Financial Services sold 200 Pfizer shares in Q3 2026, an estimated $5.32K.
  • Pfizer made up 0.38% of Miller Financial Services's portfolio in Q3 2026, its #76 holding.
  • Miller Financial Services first reported a position in Pfizer in Q4 2024 and has held it in 8 quarters since.
  • 1,861 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Miller Financial Services's 13F filing for Q3 2026, filed 20 Oct 2026.